参考文献/References:
[1] Basu Ball W,Neff JK,Gohil VM.The role of nonbilayer phospholipids in mitochondrial structure and function[J].FEBS Lett,2018,592(8):1273-1290.DOI:10.1002/1873-3468.12887.
[2] Kameoka S,Adachi Y,Okamoto K,et al.Phosphatidic acid and cardiolipin coordinate mitochondrial dynamics[J].Trends Cell Biol,2018,28(1):67-76.DOI:10.1016/j.tcb.2017.08.011.
[3] Ban T,Ishihara T,Kohno H,et al.Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin[J].Nat Cell Biol,2017,19(7):856-863.DOI:10.1038/ncb3560.
[4] Stepanyants N,Macdonald PJ,Francy CA,et al.Cardiolipin's propensity for phase transition and its reorganization by dynamin-related protein 1 form a basis for mitochondrial membrane fission[J].Mol Biol Cell,2015,26(17):3104-3116.DOI:10.1091/mbc.E15-06-0330.
[5] Chu CT,Ji J,Dagda RK,et al.Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells[J].Nat Cell Biol,2013,15(10):1197-1205.DOI:10.1038/ncb2837.
[6] Musatov A,Sedlák E.Role of cardiolipin in stability of integral membrane proteins[J].Biochimie,2017,142:102-111.DOI:10.1016/j.biochi.2017.08.013.
[7] Musatov A,Robinson NC.Bound cardiolipin is essential for cytochrome c oxidase proton translocation[J].Biochimie,2014,105:159-164.DOI:10.1016/j.biochi.2014.07.005.
[8] Gasanov SE,Kim AA,Yaguzhinsky LS,et al.Non-bilayer structures in mitochondrial membranes regulate ATP synthase activity[J].Biochim Biophys Acta Biomembr,2018,1860(2):586-599.DOI:10.1016/j.bbamem.2017.11.014.
[9] Ruprecht JJ,King MS,Zögg T,et al.The molecular mechanism of transport by the mitochondrial ADP/ATP carrier[J].Cell,2019,176(3):435-447.e15.DOI:10.1016/j.cell.2018.11.025.
[10] Paradies G,Paradies V,De Benedictis V,et al.Functional role of cardiolipin in mitochondrial bioenergetics[J].Biochim Biophys Acta,2014,1837(4):408-417.DOI:10.1016/j.bbabio.2013.10.006.
[11] Raemy E,Martinou JC.Involvement of cardiolipin in tBID-induced activation of BAX during apoptosis[J].Chem Phys Lipids,2014,179:70-74.DOI:10.1016/j.chemphyslip.2013.12.002.
[12] Bautista JS,Falabella M,Flannery PJ,et al.Advances in methods to analyse cardiolipin and their clinical applications[J].Trends Analyt Chem,2022,157:116808.DOI:10.1016/j.trac.2022.116808.
[13] Wang W,Wong NK,Bok SL,et al.Visualizing cardiolipin in situ with HKCL-1M,a highly selective and sensitive fluorescent probe[J].J Am Chem Soc,2023,145(20):11311-11322.DOI:10.1021/jacs.3c00243.
[14] Falabella M,Vernon HJ,Hanna MG,et al.Cardiolipin,mitochondria,and neurological disease[J].Trends Endocrinol Metab,2021,32(4):224-237.DOI:10.1016/j.tem.2021.01.006.
[15] Ahmadpour ST,Mahéo K,Servais S,et al.Cardiolipin,the mitochondrial signature lipid:implication in cancer[J].Int J Mol Sci,2020,21(21):8031.DOI:10.3390/ijms21218031.
[16] Whitson JA,Martín-Pérez M,Zhang T,et al.Elamipretide(SS-31)treatment attenuates age-associated post-translational modifications of heart proteins[J].Geroscience,2021,43(5):2395-2412.DOI:10.1007/s11357-021-00447-6.
[17] Yang Q,Xie W,Wang X,et al.SS31 ameliorates podocyte injury via inhibiting OMA1-Mediated hydrolysis of OPA1 in diabetic kidney disease[J].Front Pharmacol,2022,12:707006.DOI:10.3389/fphar.2021.707006.
[18] Ding XW,Robinson M,Li R,et al.Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer's disease[J].Pharmacol Res,2021,171:105783.DOI:10.1016/j.phrs.2021.105783.
[19] Zhang X,Bowen E,Zhang M,et al.SS-31 as a Mitochondrial protectant in the treatment of tendinopathy:evaluation in a murine supraspinatus tendinopathy model[J].J Bone Joint Surg Am,2022,104(21):1886-1894.DOI:10.2106/JBJS.21.01449.
[20] Shang L,Ren H,Wang S,et al.SS-31 Protects liver from ischemia-reperfusion injury via modulating macrophage polarization[J].Oxid Med Cell Longev,2021,2021:6662156.DOI:10.1155/2021/6662156.
[21] Harmsen JF,van Polanen N,van Weeghel M,et al.Circadian misalignment disturbs the skeletal muscle lipidome in healthy young men[J].FASEB J,2021,35(6):e21611.DOI:10.1096/fj.202100143R.
[22] D'Angelo V,Martinez C,Arreche N,et al.Thyroid hormone disorder and the heart:the role of cardiolipin in calcium handling[J].Exp Physiol,2023,108(3):412-419.DOI: 10.1113/EP090817.